In this study, we observed that mTORC1/2 inhibitors induce cytoprotective autophagy by activating JNK in NSCLC cells and that inhibiting autophagy or JNK activation increases NSCLC cell sensitivity to mTORC1/2 inhibitors. This evidence concerns the gene MAPK8 and non-small cell lung carcinoma.